Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Assistance Publique des Hôpitaux de Paris SA

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Established: 1849-01-01

Employees: 10K

Market Cap: -

Website: http://www.aphp.fr

Clinical Trials

Iron Deficiency (ID) in Infants

Not Applicable

Completed

Conditions: Iron Deficiency in Young Children Living in France

Interventions: Biological: Blood samples

First Posted Date: 2015-06-29

Last Posted Date: 2019-03-14

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 830

Registration Number: NCT02484274

Locations: 🇫🇷
Necker-Enfants Malades hospital, Paris, France

Analgesic Efficacy of Morphine Alone or Combined With Paracetamol and/or Ibuprofen for Long-bones Fractures in Children

Phase 3

Completed

Conditions: Pain
Long-bone Fractures

Interventions: Drug: Paracetamol
Drug: Ibuprofen
Drug: paracetamol + ibuprofen
Drug: Placebo

First Posted Date: 2015-06-22

Last Posted Date: 2019-01-18

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 304

Registration Number: NCT02477007

Locations: 🇫🇷
Paediatric emergency Armand Trousseau hospital, Paris, France

Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis

Phase 3

Completed

Conditions: Hand Osteoarthritis

Interventions: Drug: tocilizumab
Drug: saline solution

First Posted Date: 2015-06-22

Last Posted Date: 2019-07-30

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 104

Registration Number: NCT02477059

Locations: 🇫🇷
Rheumatology department Lariboisiere Hospital, Paris, Ile De France, France

Methods of Labor Induction and Perinatal Outcomes

Completed

Conditions: Induction of Labor

Interventions: Other: all women with an induced labor

First Posted Date: 2015-06-22

Last Posted Date: 2018-07-10

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 3049

Registration Number: NCT02477085

Locations: 🇫🇷
Port-Royal maternity unit, Cochin Hospital, Assistance publique des Hôpitaux de Paris (APHP, Paris, France

Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock

Phase 3

Completed

Conditions: Severe Septic Syndrome (Severe Sepsis and Septic Shock) Diagnosed and Treated by Mobile Intensive Care Unit

Interventions: Drug: Ceftriaxone
Drug: Piperacillin tazobactam
Drug: Norepinephrine
Drug: Hydrocortisone

First Posted Date: 2015-06-16

Last Posted Date: 2023-03-07

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 398

Registration Number: NCT02473263

Locations: 🇫🇷
Anesthesiology, Intensive Care Unit and emergency department - Necker Hospital, Paris, France

Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection

Not Applicable

Completed

Conditions: Vaginal Colonization With GBS

Interventions: Biological: Bacteriological analyses on clinical samples performed with Eswabs

First Posted Date: 2015-06-15

Last Posted Date: 2018-03-02

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 151

Registration Number: NCT02471937

Locations: 🇫🇷
CH Louis Mourier, Colombes, France

Treatment of Familiar Lymphohistiocytosis

Phase 1

Completed

Conditions: Hemophagocytic Lymphohistiocytosis (HLH)

Interventions: Drug: Alemtuzumab
Drug: Methyl Prednisolone (MP)
Drug: Cyclosporin A (CSA)

First Posted Date: 2015-06-15

Last Posted Date: 2021-04-15

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 29

Registration Number: NCT02472054

Locations: 🇫🇷
Hôpital Necker-Enfants Malades, Paris, France

Impact of an Early Palliative Approach

Not Applicable

Completed

Conditions: Criteria of Vulnerability

Interventions: Other: strategy promoting early consideration and collegiate vulnerability of patients

First Posted Date: 2015-06-15

Last Posted Date: 2017-06-20

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 1172

Registration Number: NCT02471976

Locations: 🇫🇷
Hôpital FOCH, Suresnes, France

Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients

Phase 1

Suspended

Conditions: Heart Transplant
Coronary Disease

Interventions: Biological: Mesenchymal cell therapy

First Posted Date: 2015-06-15

Last Posted Date: 2017-02-23

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 14

Registration Number: NCT02472002

Locations: 🇫🇷
Département de cardiologie du Pr Michel KOMADJA, Paris, France

Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study

Phase 2

Terminated

Conditions: Thyroid Cancer

Interventions: Drug: gemcitabine -oxaliplatine combination

First Posted Date: 2015-06-15

Last Posted Date: 2019-03-18

Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Target Recruit Count: 21

Registration Number: NCT02472080

Locations: 🇫🇷
Groupe Hospitalier Pitié Salpetriere, Paris, France

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy